Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nao Mai Yi Hao capsule for prevention of post-stenting cerebrovascular events in symptomatic cerebral artery stenosis
ChiCTR1800016555Phase 3Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cerebral arterial stenosis (ICAS) comparing Nao Mai Yi Hao capsule plus conventional treatment with Placebo plus conventional treatment (2 arms). Primary endpoints: Stroke event, Ischemic stroke and 3 more. Started Jun 2018; status: recruiting.
02
Drugs
Nao Mai Yi Hao capsule
03
Conditions
cerebral arterial stenosis (ICAS)
Beyond the preview
Go deeper on ChiCTR1800016555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016555.